Web Analytics Made Easy - Statcounter

Recent Regulatory Changes in Antidepressant Labels: Implicatons of Activation (2006)

  • January 28, 2006
  • /   Admin
  • /   ssris-and-other-antidepressants
More focus is needed on the risk of activation or stimulation as described in the new class of warnings from the Food and Drug Administration, including anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania and other unusual changes of behavior, worsening of depression and suicidal ideation. recentregulatory.pbreggin.2006.pdf
Back to Blogs

Recent Posts

  1. Psychiatric Drugs
  2. Peter Breggin MD Psychiatric Reform Accomplishments
  3. Dr. Breggin's Upcoming Public Presentations
  4. 17th Annual International Military and Civilian Combat Stress Conference
  5. alfredadler.org
  6. Breggin.com Newsletter Privacy Policy
  7. Making Americans into Zombies
  8. Thank you for purchasing Wow, I'm an American!
  9. Antipsychotic Drugs, their Adverse Effects, and Tort Reform
  10. Learn to Help Children Without Psychiatric Drugs

We use cookies to enhance your experience and improve our services and our website’s functionality. By continuing to use our website, including remaining on the landing page, you consent to our use of cookies.

Your items have been added to the shopping cart. The shopping cart modal has opened and here you can review items in your cart before going to checkout